Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Sequencing to Treatment: Operational Challenges in Translating Precision Oncology Into Clinical Practice.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2026
Same author

Neoadjuvant Sacituzumab Govitecan in Patients With Muscle-Invasive Bladder Cancer: Primary Results of the SURE-01 Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Ultra-high tumor mutation burden breast cancer: genomic profiling and real-world immunotherapy results.

NPJ breast cancer·2026
Same author

Homozygous Loss of Recombination Repair Genes and Poly ADP-Ribose Polymerase Inhibitor Benefit for Patients With Ovarian Cancer.

JCO precision oncology·2026
Same author

Genomics of <i>MTAP</i> Loss in >500,000 Solid Tumor Specimens Profiled Using Comprehensive Genomic Profiling Platforms.

JCO precision oncology·2026
Same author

Diabetic striatopathy associated with nonketotic hyperglycemia.

JCEM case reports·2026

Related Experiment Video

Updated: Aug 19, 2025

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.1K

Novel markers in breast pathology.

David J Dabbs1,2, Richard S Huang3, Jeffrey S Ross4

  • 1PreludeDx, Laguna Hills, CA, USA.

Histopathology
|December 5, 2022
PubMed
Summary

This review explores breast cancer biomarkers used for prognosis and treatment prediction. It highlights key techniques like immunohistochemistry, liquid biopsies, and next-generation sequencing for advancing breast pathology.

Keywords:
breastimmunohistochemistrynext generation sequencingnovel markers

More Related Videos

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

12.7K
Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.0K

Related Experiment Videos

Last Updated: Aug 19, 2025

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.1K
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

12.7K
Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.0K

Area of Science:

  • Oncology
  • Pathology
  • Biomarker Discovery

Background:

  • Breast pathology involves a growing number of biomarkers for disease detection, prognosis, and treatment prediction.
  • Biomarkers provide crucial prognostic and predictive information in managing breast cancer.
  • Understanding these markers is essential for personalized medicine approaches.

Purpose of the Study:

  • To review the current landscape of breast cancer biomarkers.
  • To focus on biomarkers utilized in immunohistochemistry, liquid biopsies, and next-generation sequencing.
  • To provide an overview of their prognostic and predictive value.

Main Methods:

  • Literature review of scientific articles and studies.
  • Focus on methodologies including immunohistochemistry, liquid biopsies, and next-generation sequencing.
  • Analysis of biomarker applications in breast pathology.

Main Results:

  • Biomarkers are integral to modern breast pathology, offering prognostic and predictive insights.
  • Immunohistochemistry remains a cornerstone for biomarker assessment.
  • Liquid biopsies and next-generation sequencing are emerging as powerful tools for biomarker analysis.

Conclusions:

  • Biomarkers are critical for personalized treatment strategies in breast cancer.
  • Advancements in techniques like next-generation sequencing are expanding biomarker utility.
  • Continued research in biomarker development is vital for improving patient outcomes.